Your Unread Messages in OncologySee All >> Messages include industry-sponsored communications and special communications from MDLinx
Top Medical News
The latest medical news making headlines from this week. Get current now!
Smartest Doc Board Exam Prep
Board Exams are heating up. Stay cool and Prep Now!
You many be eligible to request pharmaceutical samples online. Click here for more information.
1 American Medical Group Association's 2015 Medical Group Compensation and Productivity Survey reports average increase in physician compensation at 2.8 percent American Medical Group Association News, July 17, 2015
2 Fish consumption and risk of myeloma: a meta-analysis of epidemiological studies Cancer Causes and Control, July 13, 2015 Evidence Based Medicine
3 Prospective clinical utility study of the use of the 21-gene assay in adjuvant clinical decision making in women with estrogen receptor-positive early invasive breast cancer: Results from the SWITCH Study The Oncologist, July 3, 2015 Free full text
4 Effect of mammographic screening from age 40 years on breast cancer mortality in the UK Age trial at 17 years' follow-up: a randomised controlled trial The Lancet Oncology, July 24, 2015
5 Effect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer: a multicentre, phase 2 trial The Lancet Oncology, July 17, 2015
6 Afatinib versus erlotinib as second-line treatment of patients with advanced squamous cell carcinoma of the lung (LUX-Lung 8): an open-label randomised controlled phase 3 trial The Lancet Oncology, July 7, 2015
7 Gefitinib plus chemotherapy versus placebo plus chemotherapy in EGFR-mutation-positive non-small-cell lung cancer after progression on first-line gefitinib (IMPRESS): a phase 3 randomised trial The Lancet Oncology, July 9, 2015
8 Venlafaxine in management of hot flashes in women with breast cancer: a systematic review and meta-analysis Breast Cancer Research and Treatment, June 29, 2015 Evidence Based Medicine Review Article
9 Outcomes with and without axillary node dissection for node-positive lumpectomy and mastectomy patients The American Journal of Surgery, July 10, 2015
10 Adjuvant lymph-node field radiotherapy versus observation only in patients with melanoma at high risk of further lymph-node field relapse after lymphadenectomy (ANZMTG 01.02/TROG 02.01): 6-year follow-up of a phase 3, randomised controlled trial The Lancet Oncology, July 23, 2015
© 2015 M3 USA Corporation. ALL Rights Reserved.